Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Frontiers in Immunology
|
February 5, 2013
Keeping memories alive
Gabrielle T Belz, Erika Cretney
Immunologic Research
|
October 13, 2004
Re: Immunologic Research review (Zheng S-J and Chen YH. TRAIL, Bim, and Thymic-Negative Selection. Immunol. Res. 2003; 28/3:295-301)
Mark J Smyth, Erika Cretney
The International Journal of Biochemistry & Cell Biology
|
November 14, 2006
Cancer: novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway
Erika Cretney, Kazuyoshi Takeda, Mark J Smyth
Trends in Immunology
|
December 11, 2012
Differentiation and function of Foxp3(+) effector regulatory T cells
Erika Cretney, Axel Kallies, Stephen L Nutt
Immunology and Cell Biology
|
September 13, 2002
TNF contributes to the immunopathology of perforin/Fas ligand double deficiency
Erika Cretney, Shayna E A Street, Mark J Smyth
Immunological Reviews
|
November 18, 2004
Cytokines in cancer immunity and immunotherapy
Mark J Smyth, Erika Cretney, Michael H Kershaw, et al.
Immunology and Cell Biology
|
January 13, 2006
TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer
Erika Cretney, Anil Shanker, Hideo Yagita, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2002
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
Erika Cretney, Kazuyoshi Takeda, Hideo Yagita, et al.
The Journal of Experimental Medicine
|
September 1, 2005
NKG2D function protects the host from tumor initiation
Mark J Smyth, Jeremy Swann, Erika Cretney, et al.
International Immunology
|
January 15, 2008
No requirement for TRAIL in intrathymic negative selection
Erika Cretney, Adam P Uldrich, Finlay W McNab, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Frontiers in Immunology
|
February 5, 2013
Keeping memories alive
Gabrielle T Belz, Erika Cretney
Immunologic Research
|
October 13, 2004
Re: Immunologic Research review (Zheng S-J and Chen YH. TRAIL, Bim, and Thymic-Negative Selection. Immunol. Res. 2003; 28/3:295-301)
Mark J Smyth, Erika Cretney
The International Journal of Biochemistry & Cell Biology
|
November 14, 2006
Cancer: novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway
Erika Cretney, Kazuyoshi Takeda, Mark J Smyth
Trends in Immunology
|
December 11, 2012
Differentiation and function of Foxp3(+) effector regulatory T cells
Erika Cretney, Axel Kallies, Stephen L Nutt
Immunology and Cell Biology
|
September 13, 2002
TNF contributes to the immunopathology of perforin/Fas ligand double deficiency
Erika Cretney, Shayna E A Street, Mark J Smyth
Immunological Reviews
|
November 18, 2004
Cytokines in cancer immunity and immunotherapy
Mark J Smyth, Erika Cretney, Michael H Kershaw, et al.
Immunology and Cell Biology
|
January 13, 2006
TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer
Erika Cretney, Anil Shanker, Hideo Yagita, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2002
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
Erika Cretney, Kazuyoshi Takeda, Hideo Yagita, et al.
The Journal of Experimental Medicine
|
September 1, 2005
NKG2D function protects the host from tumor initiation
Mark J Smyth, Jeremy Swann, Erika Cretney, et al.
International Immunology
|
January 15, 2008
No requirement for TRAIL in intrathymic negative selection
Erika Cretney, Adam P Uldrich, Finlay W McNab, et al.
Page
of 4